Seeing Machines Limited
22 May 2007
22 May 2007
Seeing Machines Limited
('Seeing Machines' or the 'Company')
SEEING MACHINES LICENSES faceAPI PRODUCT
Seeing Machines (AIM: SEE), a leading developer of advanced computer based
imaging software systems, announces today that the Company has signed a
technology licensing agreement with a North American based computer vision
company. Seeing Machines will provide its unique faceAPI based head tracking
technology to the client for use within their applications. Seeing Machines will
receive a license fee for each product sold that incorporates the faceAPI
product. The terms of the licensing agreement are the subject of a
confidentiality agreement and have not been disclosed.
Nick Cerneaz, CEO of Seeing Machines, commented: 'Signing this agreement is
directly aligned with our business strategy to generate revenue from licensing
our core technology to other product and application developers. This licensing
agreement builds on the foundations for our faceAPI business laid over the last
2 years of development and we are looking to build this line of our business
further in the coming year.'
Further information about Seeing Machines can be obtained from the company
website www.seeingmachines.com.
--- ENDS ---
Enquiries:
Seeing Machines Limited Insinger de Beaufort Parkgreen Communications
Nick Cerneaz, CEO Peter Ward Erica Nelson
+61 (0) 2 6125 6501 +44 (0) 20 7190 7015 +44 (0) 20 7851 7480
www.seeingmachines.com
Notes to editors:
About Seeing Machines
Seeing Machines is an award winning Technology Company which focuses on vision
based human machine interfaces. Formed in 2000 in Canberra, Australia, Seeing
Machines' purpose is to commercialise its computer-vision across a range of
industries and applications.
Seeing Machines deliver advanced computer vision solutions for researches and
developers in human factors, transportation safety, computer human interaction,
robotics, medical research and psychology. The flagship product faceLAB(R)
provides an automated and contact-free gaze and head tracking technology, it
solves the problem of observing human behaviour naturally, non-intrusively and
with a high degree of accuracy and usability. The underlying head pose, eye gaze
and facial feature tracking technologies within faceLAB(R) are also packaged in
the faceAPITM product that is available to third party integrators and
application developers allowing them to incorporate that functionality in their
own developments.
Building on these unique face tracking and pupil measurement and monitoring
capabilities, Seeing Machines is also developing the TrueField Analyzer(R), a
new ophthalmic device to help clinicians detect and manage glaucoma (and a range
of other diseases of the human visual system).
Seeing Machines' faceLAB(R) product is a computer vision system that is able to
measure the orientation and position of a human head, as well as detect blinks
and estimate gaze-direction. It achieves all of this completely visually through
a stereo camera system connected to advanced image processing software, with no
attachments required on the subject. The product is designed to allow human
factors researchers and designers assess the interaction of an operator in an
environment and this finds application in designing operator environments, such
as cockpits for cars, trucks, trains, and aeroplanes for instance, and other
industrial design applications, as well as medical and psychological research
situations. The technology also has application in monitoring automobile drivers
and if it detects drowsiness or that the driver is distracted and their
attention has been diverted from the road, an alarm can be raised to alert the
driver to either pull over and rest in the case of drowsiness or to pay more
attention to the road.
faceLAB(R) works in real-time, enabling the behaviour of a subject to be
tracked. This technology is paving the way in promoting safer driving conditions
and works to enhance the driving experience and to eliminate accidents caused
through driver drowsiness or distraction.
In addition to the capabilities outlined above the faceAPITMsuite also includes
extensive monocular tracking solutions, high precision eye and pupil tracking
and monitoring capabilities, advanced automatic initialization and automatic
background operating modes. The product is a fully featured solution allowing
both automated and manual control modes and providing the host application with
extensive information about the user(s) being monitored by the tracking system.
There are many different sectors that can benefit from this revolutionary
software, for which it has been developed, including: automotive; academic
research; medicine/healthcare; defence; autostereoscopy (next generation
displays); sport; and games.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.